BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02206763-completion@plaintrial.com
DTSTAMP:20261110T235510Z
DTSTART;VALUE=DATE:20170216
SUMMARY:Erlotinib and Momelotinib for the Treatment of Epidermal Growth Fac
 tor Receptor (EGFR) Mutated EGFR Tyrosine Kinase Inhibitor (TKI) Naive Met
 astatic Non-Small Cell Lung Cancer (NSCLC) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02206763
URL:https://plaintrial.com/trial/NCT02206763
END:VEVENT
END:VCALENDAR